GEMTUZUMAB OZOGAMICIN

3665 reported adverse events

Drug classes: CD33-directed Immunoconjugate [EPC]

These side effects are most commonly reported by patients taking GEMTUZUMAB OZOGAMICIN:

# Side effect Count
0 FEBRILE NEUTROPENIA 698
1 PYREXIA 326
2 SEPSIS 302
3 VENOOCCLUSIVE LIVER DISEASE 260
4 THROMBOCYTOPENIA 240
5 PLATELET COUNT DECREASED 236
6 PNEUMONIA 197
7 NEUTROPENIA 194
8 WHITE BLOOD CELL COUNT DECREASED 185
9 ASPARTATE AMINOTRANSFERASE INCREASED 184
See all common reactions for GEMTUZUMAB OZOGAMICIN

GEMTUZUMAB OZOGAMICIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VENOOCCLUSIVE LIVER DISEASE 260 0.0526
1 VENOOCCLUSIVE DISEASE 109 0.0435
2 ACUTE MYELOID LEUKAEMIA RECURRENT 51 0.0237
3 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 20 0.0216
4 NEUTROPENIC INFECTION 17 0.0178
5 BLAST CELL COUNT INCREASED 18 0.0172
6 LEUKAEMIA RECURRENT 29 0.0171
7 NEUTROPENIC COLITIS 29 0.0140
8 BLOOD CULTURE POSITIVE 36 0.0120
9 FEBRILE NEUTROPENIA 698 0.0105
See all enriched reactions for GEMTUZUMAB OZOGAMICIN